Candel Therapeutics' Progress Fuels Anticipation for Prostate and Lung Cancer Programs
Market Chameleon (Fri, 15-May 11:44 AM)
Candel Therapeutics Highlights Progress on Phase 3 Trials and Expanding Clinical Pipeline Ahead of Investor Conferences
Market Chameleon (Thu, 14-May 10:26 AM)
